Osteocytes and Bone Metastasis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Buenrostro, 2016, The Bone Microenvironment: a Fertile Soil for Tumor Growth, Curr Qsteoporos Rep, 14, 10.1007/s11914-016-0315-2
Chin, 2015, Bone Metastasis: Concise Overview. Federal practitioner : for the health care professionals of the VA, DoD PHS, 32, 24
de Azevedo, 2020, Biology and pathogenesis of human osteosarcoma, Oncol Lett, 19, 10.3892/ol.2019.11229
Terpos, 2014, Management of bone disease in multiple myeloma, Expert Rev Hematol, 7, 10.1586/17474086.2013.874943
Hernandez, 2018, Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States, BMC Cancer, 18, 44, 10.1186/s12885-017-3922-0
Wang, 2015, The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells, Cancer Cell, 27, 193, 10.1016/j.ccell.2014.11.017
Liu, 2016, Characteristics and Significance of the Pre-metastatic Niche, Cancer Cell, 30, 10.1016/j.ccell.2016.09.011
Kwakwa, 2017, Integrin alphavbeta3 Signaling in Tumor-Induced Bone Disease, Cancers, 9, 10.3390/cancers9070084
Pecheur, 2002, Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone, FASEB J, 16, 10.1096/fj.01-0911fje
Weidle, 2016, Molecular Mechanisms of Bone Metastasis, Cancer Genomics Proteomics, 13, 1, 10.21873/cgp.20004
Cox, 2015, The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase, Nature, 522, 10.1038/nature14492
Walker, 2018, Role of Extracellular Matrix in Development and Cancer Progression, Int J Mol Sci, 19, 10.3390/ijms19103028
Monteiro, 2013, T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer, PloS One, 8, 10.1371/journal.pone.0068171
Wu, 2018, Molecular Regulation of Bone Metastasis Pathogenesis, Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol, 46, 10.1159/000489184
Chen, 2010, Breast cancer metastasis to the bone: mechanisms of bone loss, Breast Cancer Res BCR, 12, 215, 10.1186/bcr2781
Pellegatti, 2011, P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration, FASEB J, 25, 10.1096/fj.10-169854
Kearns, 2008, Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease, Endocr Rev, 29, 10.1210/er.2007-0014
Gralow, 2007, Managing metastatic bone pain: the role of bisphosphonates, J Pain Symptom Manage, 33, 10.1016/j.jpainsymman.2007.01.001
Kang, 2003, A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, 3, 10.1016/S1535-6108(03)00132-6
Soki, 2012, The multifaceted actions of PTHrP in skeletal metastasis, Future Oncol (Lond Engl), 8, 10.2217/fon.12.76
Ell, 2013, Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis, Cancer Cell, 24, 10.1016/j.ccr.2013.09.008
Colombo, 2014, Notch signaling drives multiple myeloma induced osteoclastogenesis, Oncotarget, 5, 10.18632/oncotarget.2084
Delgado-Calle, 2016, Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma, Cancer Res, 76, 10.1158/0008-5472.CAN-15-1703
Andrade, 2017, RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis, Sci Trans Med, 9, 10.1126/scitranslmed.aai9338
Knowles, 2019, The Adenosine A2B Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments, Cells, 8, 10.3390/cells8060624
Dirckx, 2019, The role of osteoblasts in energy homeostasis, Nat Rev Endocrinol, 15, 10.1038/s41574-019-0246-y
Weichhaus, 2015, Osteoprotegerin in breast cancer: beyond bone remodeling, Mol Cancer, 14, 117, 10.1186/s12943-015-0390-5
Tawara, 2011, Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies, Cancer Manage Res, 3, 10.2147/CMAR.S18101
Shiozawa, 2008, Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer, J Cell Biochem, 105, 10.1002/jcb.21835
Shiozawa, 2011, Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow, J Clin Invest, 121, 10.1172/JCI43414
Capulli, 2019, Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry, Br J Cancer, 121, 10.1038/s41416-019-0501-y
Widner, 2018, Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy, Curr Qsteoporos Rep, 16, 596, 10.1007/s11914-018-0471-7
Sosnoski, 2015, Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment, Clin Exp Metastasis, 32, 10.1007/s10585-015-9710-9
Johnson, 2016, Erratum: Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow, Nat Cell Biol, 18, 1260, 10.1038/ncb3433
Kobayashi, 2011, Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone, J Exp Med, 208, 10.1084/jem.20110840
Yu-Lee, 2018, Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway, Cancer Res, 78, 10.1158/0008-5472.CAN-17-1051
Yumoto, 2016, Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow, Sci Rep, 6, 10.1038/srep36520
Lawson, 2015, Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche, Nat Commun, 6, 8983, 10.1038/ncomms9983
Botolin, 2007, Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice, Endocrinology, 148, 198, 10.1210/en.2006-1006
Burghardt, 2010, High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus, J Clin Endocrinol Metab, 95, 10.1210/jc.2010-0226
Vestergaard, 2007, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis, Osteoporos Int J established as result cooperation between Eur Foundation Osteoporos Natl Osteoporos Foundation USA, 18, 10.1007/s00198-006-0253-4
Zong, 2016, Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice, Oncol Rep, 35, 10.3892/or.2015.4430
Campbell, 2012, Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice, PloS Biol, 10, 10.1371/journal.pbio.1001363
Katz, 2010, Osteoporosis and gastrointestinal disease, Gastroenterol Hepatol, 6
Balkwill, 2001, Inflammation and cancer: back to Virchow, Lancet (Lond Engl), 357, 10.1016/S0140-6736(00)04046-0
Lee, 1994, Effect of trauma on implantation of metastatic tumor in bone in mice, J Surg Oncol, 56, 10.1002/jso.2930560311
Alieva, 2018, Potential impact of invasive surgical procedures on primary tumor growth and metastasis, Clin Exp Metastasis, 35, 10.1007/s10585-018-9896-8
Demicheli, 2008, The effects of surgery on tumor growth: a century of investigations, Ann Oncol, 19, 10.1093/annonc/mdn386
Krall, 2018, The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy, Sci Trans Med, 10, 10.1126/scitranslmed.aan3464
Campisi, 2007, Cellular senescence: when bad things happen to good cells, Nat Rev Mol Cell Biol, 8, 10.1038/nrm2233
Alspach, 2013, Senescence and the pro-tumorigenic stroma, Crit Rev Oncogenesis, 18, 10.1615/CritRevOncog.2014010630
Luo, 2016, Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development, Cell Rep, 14, 82, 10.1016/j.celrep.2015.12.016
Li, 2014, B Cell Production of Both OPG and RANKL is Significantly Increased in Aged Mice, Open Bone J, 6, 8, 10.2174/1876525401406010008
Ottewell, 2014, Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo, Clin Cancer Res, 20, 10.1158/1078-0432.CCR-13-1246
Schosserer, 2017, The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy, Front Oncol, 7, 10.3389/fonc.2017.00278
Lee, 2019, The dynamic nature of senescence in cancer, Nat Cell Biol, 21, 94, 10.1038/s41556-018-0249-2
Lynch, 2013, In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model, J Bone Mineral Res, 28, 10.1002/jbmr.1966
Kothari, 2016, Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition, J Clin Med, 5, 10.3390/jcm5040039
Fan, 2020, Skeletal loading regulates breast cancer-associated osteolysis in a loading intensity-dependent fashion, Bone Res, 8, 9, 10.1038/s41413-020-0083-6
Delgado-Calle, 2014, Role of osteocytes in multiple myeloma bone disease, Curr Opin Support Palliative Care, 8, 10.1097/SPC.0000000000000090
Zhou, 2016, Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis, Oncogene, 35, 10.1038/onc.2016.101
McDonald, 2017, Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease, Curr Qsteoporos Rep, 15, 10.1007/s11914-017-0403-y
Robling, 2020, The Osteocyte: New Insights, Annu Rev Physiol, 82, 485, 10.1146/annurev-physiol-021119-034332
Delgado-Calle, 2017, Role and mechanism of action of sclerostin in bone, Bone, 96, 29, 10.1016/j.bone.2016.10.007
Xiong, 2015, Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone, PloS One, 10, 10.1371/journal.pone.0138189
D’Oronzo, 2020, Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer, Int J Mol Sci, 21, 10.3390/ijms21083022
Gnant, 2019, Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet Oncol, 20, 10.1016/S1470-2045(18)30862-3
Coleman, 2020, Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial, Lancet Oncol, 21, 60, 10.1016/S1470-2045(19)30687-4
Plotkin, 2015, Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor kappaB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading, J Biol Chem, 290, 10.1074/jbc.M115.642090
McCutcheon, 2020, Apoptotic Osteocytes Induce RANKL Production in Bystanders via Purinergic Signaling and Activation of Pannexin Channels, J Bone Mineral Res, 35, 10.1002/jbmr.3954
Kameda, 1997, Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts, J Exp Med, 186, 10.1084/jem.186.4.489
Ma, 2019, Connexin 43 hemichannels protect bone loss during estrogen deficiency, Bone Res, 7, 11, 10.1038/s41413-019-0050-2
Li, 2020, Deletion of p16 prevents estrogen deficiency-induced osteoporosis by inhibiting oxidative stress and osteocyte senescence, Am J Trans Res, 12
Kousteni, 2001, Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity, Cell, 104, 10.1016/S0092-8674(01)00268-9
Takeshita, 2014, Age-related marrow adipogenesis is linked to increased expression of RANKL, J Biol Chem, 289, 10.1074/jbc.M114.547919
Coleman, 2014, Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial, Lancet Oncol, 15, 997, 10.1016/S1470-2045(14)70302-X
2015, Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials, Lancet (Lond Engl), 386, 10.1016/S0140-6736(15)60908-4
Wang, 2019, Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion, Oncogene, 38, 10.1038/s41388-019-0736-3
Sottnik, 2015, Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases, Cancer Res, 75, 10.1158/0008-5472.CAN-14-2493
Ma, 2018, Mechanical regulation of breast cancer migration and apoptosis via direct and indirect osteocyte signaling, J Cell Biochem, 119, 10.1002/jcb.26745
Giuliani, 2012, Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation, Leukemia, 26, 10.1038/leu.2011.381
Riquelme, 2020, The Role of Connexin Channels in the Response of Mechanical Loading and Unloading of Bone, Int J Mol Sci, 21, 10.3390/ijms21031146
Xu, 2015, Connexin 43 channels are essential for normal bone structure and osteocyte viability, J Bone Mineral Res, 30, 10.1002/jbmr.2374
Kar, 2013, Connexin 43 channels protect osteocytes against oxidative stress-induced cell death, J Bone Mineral Res, 28, 10.1002/jbmr.1917
Bellido, 2011, Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability, Bone, 49, 10.1016/j.bone.2010.08.008
Zhou, 2015, Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis, Oncogene, 34, 10.1038/onc.2014.113
Genetos, 2007, Oscillating fluid flow activation of gap junction hemichannels induces ATP release from MLO-Y4 osteocytes, J Cell Physiol, 212, 10.1002/jcp.21021
Di Virgilio, 2018, Extracellular ATP and P2 purinergic signalling in the tumour microenvironment, Nat Rev Cancer, 18, 10.1038/s41568-018-0037-0
Feng, 2020, The yin and yang functions of extracellular ATP and adenosine in tumor immunity, Cancer Cell Int, 20, 110, 10.1186/s12935-020-01195-x
Rapaport, 1983, Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5’-triphosphate, Cancer Res, 43
Beijer, 2009, Effect of adenosine 5’-triphosphate infusions on the nutritional status and survival of preterminal cancer patients, Anti-cancer Drugs, 20, 10.1097/CAD.0b013e32832d4f22
Agteresch, 2003, Randomized clinical trial of adenosine 5’-triphosphate on tumor growth and survival in advanced lung cancer patients, Anti-cancer Drugs, 14, 10.1097/00001813-200309000-00009
Agteresch, 2000, Randomized clinical trial of adenosine 5’-triphosphate in patients with advanced non-small-cell lung cancer, J Natl Cancer Institute, 92, 10.1093/jnci/92.4.321
Furlow, 2015, Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival, Nat Cell Biol, 17, 10.1038/ncb3194
Miyazaki, 2012, Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption, J Biol Chem, 287, 10.1074/jbc.M112.385369
Schenk, 2011, ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors, Sci Signaling, 4, ra12, 10.1126/scisignal.2001270
Canale, 2018, CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells, Cancer Res, 78, 10.1158/0008-5472.CAN-16-2684
Kazemi, 2018, Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer, J Cell Physiol, 233, 10.1002/jcp.25873
Pellegatti, 2008, Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase, PloS One, 3, 10.1371/journal.pone.0002599
Allard, 2020, On the mechanism of anti-CD39 immune checkpoint therapy, J Immunotherapy Cancer, 8, 10.1136/jitc-2019-000186
Hirata, 2018, CD150(high) Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine, Cell Stem Cell, 22, 445, 10.1016/j.stem.2018.01.017